APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neglected Tropical Diseases Drugs and Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Neglected Tropical Diseases Drugs and Vaccine Market Outlook and Growth Opportunities 2026

19 December 2025192 pages

Choose your research edition.

Industry ResearchNeglected Tropical Diseases Drugs and Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neglected Tropical Diseases Drugs and Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Neglected Tropical Diseases Drugs and Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neglected Tropical Diseases Drugs and Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neglected Tropical Diseases Drugs and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neglected Tropical Diseases Drugs and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neglected Tropical Diseases Drugs and Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neglected Tropical Diseases Drugs and Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neglected Tropical Diseases Drugs and Vaccine market include Artecef BV, Cipla, Lupin, Macleods Pharmaceuticals, Ranbaxy Labs, Romark Laboratories, Sanofi-Aventis, Toyama Chemica and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Neglected Tropical Diseases Drugs and Vaccine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neglected Tropical Diseases Drugs and Vaccine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neglected Tropical Diseases Drugs and Vaccine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neglected Tropical Diseases Drugs and Vaccine market.

Neglected Tropical Diseases Drugs and Vaccine Segment by Company

Artecef BV

Cipla

Lupin

Macleods Pharmaceuticals

Ranbaxy Labs

Romark Laboratories

Sanofi-Aventis

Toyama Chemica

AstraZeneca

GlaxoSmithKline

Novartis

Neglected Tropical Diseases Drugs and Vaccine Segment by Type

Ebola

Dengue

Leishmaniasis

Chagas

Malaria

Other

Neglected Tropical Diseases Drugs and Vaccine Segment by Application

Drugs

Vaccines

Neglected Tropical Diseases Drugs and Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Neglected Tropical Diseases Drugs and Vaccine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neglected Tropical Diseases Drugs and Vaccine key companies, revenue, market share, and recent developments.

3. To split the Neglected Tropical Diseases Drugs and Vaccine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neglected Tropical Diseases Drugs and Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neglected Tropical Diseases Drugs and Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Neglected Tropical Diseases Drugs and Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neglected Tropical Diseases Drugs and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neglected Tropical Diseases Drugs and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neglected Tropical Diseases Drugs and Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neglected Tropical Diseases Drugs and Vaccine industry.

Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neglected Tropical Diseases Drugs and Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neglected Tropical Diseases Drugs and Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neglected Tropical Diseases Drugs and Vaccine Industry Trends Table 2. Neglected Tropical Diseases Drugs and Vaccine Industry Drivers Table 3. Neglected Tropical Diseases Drugs and Vaccine Industry Opportunities and Challenges Table 4. Neglected Tropical Diseases Drugs and Vaccine Industry Restraints Table 5. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Company (2021-2026) Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Key Company Manufacturing Base & Headquarters Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Company, Product Type & Application Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neglected Tropical Diseases Drugs and Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ebola Table 15. Significant Companies of Dengue Table 16. Significant Companies of Leishmaniasis Table 17. Significant Companies of Chagas Table 18. Significant Companies of Malaria Table 19. Significant Companies of Other Table 20. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type (2021-2026) Table 24. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Drugs Table 26. Significant Companies of Vaccines Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application (2021-2026) Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application (2027-2032) Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Region (2021-2026) Table 35. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Region (2027-2032) Table 37. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Market Share by Country (2021-2026) Table 40. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Market Share by Country (2027-2032) Table 42. Artecef BV Company Information Table 43. Artecef BV Business Overview Table 44. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 46. Artecef BV Recent Development Table 47. Cipla Company Information Table 48. Cipla Business Overview Table 49. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 51. Cipla Recent Development Table 52. Lupin Company Information Table 53. Lupin Business Overview Table 54. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 56. Lupin Recent Development Table 57. Macleods Pharmaceuticals Company Information Table 58. Macleods Pharmaceuticals Business Overview Table 59. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 61. Macleods Pharmaceuticals Recent Development Table 62. Ranbaxy Labs Company Information Table 63. Ranbaxy Labs Business Overview Table 64. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 66. Ranbaxy Labs Recent Development Table 67. Romark Laboratories Company Information Table 68. Romark Laboratories Business Overview Table 69. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 71. Romark Laboratories Recent Development Table 72. Sanofi-Aventis Company Information Table 73. Sanofi-Aventis Business Overview Table 74. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 76. Sanofi-Aventis Recent Development Table 77. Toyama Chemica Company Information Table 78. Toyama Chemica Business Overview Table 79. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 81. Toyama Chemica Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 86. AstraZeneca Recent Development Table 87. GlaxoSmithKline Company Information Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 91. GlaxoSmithKline Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio Table 96. Novartis Recent Development Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Neglected Tropical Diseases Drugs and Vaccine Product Image Figure 2. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Neglected Tropical Diseases Drugs and Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ebola Image Figure 8. Dengue Image Figure 9. Leishmaniasis Image Figure 10. Chagas Image Figure 11. Malaria Image Figure 12. Other Image Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type (2021-2032) Figure 16. Drugs Image Figure 17. Vaccines Image Figure 18. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application (2021-2032) Figure 21. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 24. North America Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. South America Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Ebola
  • Dengue
  • Leishmaniasis
  • Chagas
  • Malaria
  • Other
Applications
  • Drugs
  • Vaccines
Companies covered
  • Artecef BV
  • Cipla
  • Lupin
  • Macleods Pharmaceuticals
  • Ranbaxy Labs
  • Romark Laboratories
  • Sanofi-Aventis
  • Toyama Chemica
  • AstraZeneca
  • GlaxoSmithKline
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
  1. 2.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
  2. 2.2 Neglected Tropical Diseases Drugs and Vaccine Industry Drivers
  3. 2.3 Neglected Tropical Diseases Drugs and Vaccine Industry Opportunities and Challenges
  4. 2.4 Neglected Tropical Diseases Drugs and Vaccine Industry Restraints
3 Neglected Tropical Diseases Drugs and Vaccine Market by Company
  1. 3.1 Global Neglected Tropical Diseases Drugs and Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Neglected Tropical Diseases Drugs and Vaccine Company Ranking (2024-2026)
  4. 3.4 Global Neglected Tropical Diseases Drugs and Vaccine Company Manufacturing Base and Headquarters
  5. 3.5 Global Neglected Tropical Diseases Drugs and Vaccine Company Product Type and Application
  6. 3.6 Global Neglected Tropical Diseases Drugs and Vaccine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neglected Tropical Diseases Drugs and Vaccine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neglected Tropical Diseases Drugs and Vaccine Market by Type
  1. 4.1 Neglected Tropical Diseases Drugs and Vaccine Type Introduction
  2. 4.1.1 Ebola
  3. 4.1.2 Dengue
  4. 4.1.3 Leishmaniasis
  5. 4.1.4 Chagas
  6. 4.1.5 Malaria
  7. 4.1.6 Other
  8. 4.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Type
  9. 4.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Type (2021-2032)
  11. 4.2.3 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type (2021-2032)
5 Neglected Tropical Diseases Drugs and Vaccine Market by Application
  1. 5.1 Neglected Tropical Diseases Drugs and Vaccine Application Introduction
  2. 5.1.1 Drugs
  3. 5.1.2 Vaccines
  4. 5.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Application
  5. 5.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Application (2021-2032)
  7. 5.2.3 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application (2021-2032)
6 Neglected Tropical Diseases Drugs and Vaccine Regional Value Analysis
  1. 6.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032)
  7. 6.3.2 North America Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032)
  10. 6.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032)
  16. 6.6.2 South America Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Country, 2025 VS 2032
7 Neglected Tropical Diseases Drugs and Vaccine Country-level Value Analysis
  1. 7.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neglected Tropical Diseases Drugs and Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neglected Tropical Diseases Drugs and Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Artecef BV
  2. 8.1.1 Artecef BV Company Information
  3. 8.1.2 Artecef BV Business Overview
  4. 8.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  6. 8.1.5 Artecef BV Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Lupin
  14. 8.3.1 Lupin Company Information
  15. 8.3.2 Lupin Business Overview
  16. 8.3.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  18. 8.3.5 Lupin Recent Developments
  19. 8.4 Macleods Pharmaceuticals
  20. 8.4.1 Macleods Pharmaceuticals Company Information
  21. 8.4.2 Macleods Pharmaceuticals Business Overview
  22. 8.4.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  24. 8.4.5 Macleods Pharmaceuticals Recent Developments
  25. 8.5 Ranbaxy Labs
  26. 8.5.1 Ranbaxy Labs Company Information
  27. 8.5.2 Ranbaxy Labs Business Overview
  28. 8.5.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  30. 8.5.5 Ranbaxy Labs Recent Developments
  31. 8.6 Romark Laboratories
  32. 8.6.1 Romark Laboratories Company Information
  33. 8.6.2 Romark Laboratories Business Overview
  34. 8.6.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  36. 8.6.5 Romark Laboratories Recent Developments
  37. 8.7 Sanofi-Aventis
  38. 8.7.1 Sanofi-Aventis Company Information
  39. 8.7.2 Sanofi-Aventis Business Overview
  40. 8.7.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  42. 8.7.5 Sanofi-Aventis Recent Developments
  43. 8.8 Toyama Chemica
  44. 8.8.1 Toyama Chemica Company Information
  45. 8.8.2 Toyama Chemica Business Overview
  46. 8.8.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  48. 8.8.5 Toyama Chemica Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Portfolio
  66. 8.11.5 Novartis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst